• Skip to main content
  • Skip to footer

Doyle APC

California Product Liability Attorneys

  • The Firm
  • Practice Areas
    • DEFECTIVE CONSUMER PRODUCTS
    • Defective Medical Products
    • Video Game Addiction
    • CLASS ACTIONS
    • Data Breach Lawsuits
  • Cases
  • News
  • Contact

Covidien Parietex Hernia Mesh Lawsuits

Thousands of patients have filed injury lawsuits against Covidien over serious complications from defective hernia mesh implants. Many of these individuals face debilitating chronic pain, infections, and require additional, high-risk surgeries to repair the damage caused by this medical device.

As a Southern California law firm focused on complex product liability, we handle the most serious hernia mesh injury cases, including those other firms have turned away.

While Ethicon, Atrium, Bard, and other manufacturers have settled their hernia mesh lawsuits, Covidien has not. Covidien cases remain in active litigation and will continue into 2027 and beyond. On August 4, 2026, the first Covidien case to reach a jury returned an $88 million verdict for the plaintiff in federal court in Boston, the largest in any hernia mesh trial to date, with roughly 10,000 claims still pending against Medtronic nationwide. Our current hernia mesh practice is focused exclusively on cases involving Covidien’s polyester-based mesh products where complications have required at least one revision surgery.

Status of the Covidien Hernia Mesh MDL (No. 3029)

Last Updated: August 4, 2026

Federal and State Court Cases

Lawsuits involving Covidien’s Parietex polyester mesh products continue in federal and state courts. As of mid 2026, more than 2,400 lawsuits against Covidien are consolidated in federal multidistrict litigation before the U.S. District Court for the District of Massachusetts, captioned In re Covidien Hernia Mesh Products Liability Litigation No. II, No. 22-md-03029-PBS (MDL No. 3029). Roughly 7,450 additional plaintiffs have cases pending in Massachusetts state court, with more in Minnesota. In all, Medtronic (Covidien’s parent company) now faces more than 10,000 hernia mesh claims nationwide.

The MDL, overseen by Judge Patti B. Saris, has progressed through extensive discovery, with nearly 2 million documents produced and dozens of Covidien witnesses deposed. The court-ordered mediation deadline of January 14, 2026 passed without a global settlement. Covidien tried its first case rather than resolve it, and lost.

Key Case Developments

First Bellwether Trial: $88 Million Plaintiff Verdict (August 4, 2026)

A federal jury in Boston returned an $88 million verdict against Covidien in Patterson v. Covidien, Inc., No. 22-cv-10153-PBS, the first Covidien hernia mesh case in the country to reach a jury. The award was $77 million to the plaintiff and $11 million to his wife on her loss of consortium claim. The jury found that Covidien failed to give adequate warning of the dangers posed by its Symbotex mesh.

The plaintiff, a 61 year old Alabama man implanted with Symbotex during a 2017 hernia repair, proved that the mesh’s collagen layer resorbed prematurely, leading to severe adhesions, a bowel obstruction, and a small bowel resection that removed roughly three inches of intestine. He described continuing problems since that surgery, including a non healing wound, recurrent hernias, and periodic infections.

The jury declined to award punitive damages and did not find fraud. The full $88 million is compensatory, meaning it reflects what the jury concluded the injuries themselves were worth.

Covidien’s own scientists testified that Symbotex’s protective collagen barrier begins deteriorating within hours and fully breaks down within about seven days, while sales representatives were trained to tell surgeons the barrier lasted up to 30 days. The case was not simply that the device was defective, but that the implanting surgeon was never told how long the barrier would actually protect his patient’s bowel. The jury accepted that failure to warn theory. Medtronic has said it will challenge the verdict through post-trial motions and appeal.

The verdict follows Judge Saris’s June 2, 2026 ruling denying the bulk of Covidien’s motion for summary judgment, which cleared nearly all of the Patterson claims for trial. The court found that a reasonable jury could conclude that Covidien knowingly misrepresented how long Symbotex’s collagen barrier lasts and the risk that posed to patients. Because those theories apply broadly across the litigation, both the ruling and the verdict speak directly to the thousands of pending Covidien cases.

Additional bellwether cases involving Symbotex and Parietex Composite mesh products are being prepared and will follow Patterson. Those cases will now be tried, or negotiated, against an eight figure plaintiff verdict.

What the $88 Million Verdict Means for Pending Cases

A single verdict does not resolve anyone else’s case. What it does is change the arithmetic on both sides of the table.

Before August 4, Covidien could argue that its warnings were adequate and that no jury had ever said otherwise. That argument is gone. Every claim in the MDL and in the Massachusetts and Minnesota state dockets is now valued against that verdict.

Manufacturers facing this posture generally do one of two things. They try more cases in the hope of a defense verdict that resets expectations, or they move toward global resolution. Bard chose the second path in 2024 after its own trial losses. Covidien has said it will fight this verdict on post-trial motions and appeal, which suggests it intends to test the first path before it seriously negotiates.

For patients, the practical point is simple. Claims filed and worked up before a settlement framework exists are the ones in position when one arrives. Claims that are undocumented, or barred by a limitations period that ran while the client waited, are not.

Injuries That Lead to Revision Surgery

Patients with defective hernia mesh often report painful and life-altering complications. These problems can emerge months or even years after surgery, making it difficult for patients and doctors to connect the symptoms to the implant.

Our firm focuses on cases where patients have experienced severe complications such as:

  • Chronic Pain and Foreign Body Sensation: Patients can experience persistent, debilitating pain in the abdomen, groin, or leg, often described as a constant pulling, burning, stiffness, or the sensation of a hard, foreign object inside the body. This can happen when the mesh shrinks and hardens, pulling on nerves and tissue.
  • Adhesions, Bowel Obstruction, and Perforation: The mesh material can incite a severe inflammatory response, causing dense scar tissue (adhesions) to form that binds the mesh to the intestines or other organs. The result can be a life-threatening bowel obstruction, or erosion of the mesh through the intestinal wall.
  • Mesh Migration and Failure: Defective mesh can shrink, unravel, or break apart inside the body. Fragments can then migrate from the original implant site, potentially damaging other organs or tissues. This structural failure often leads to a recurrence of the original hernia.
  • Recurring and Chronic Infections: The porous nature of hernia mesh, particularly degrading polyester, can harbor bacteria and lead to chronic infections that do not respond to antibiotics. In severe cases, this can lead to sepsis, abscess formation, or emergency surgery to remove the infected device.
  • Nerve Damage and Testicular Complications: In inguinal hernia repairs, mesh can entrap or damage nerves in the groin, causing chronic pain or numbness. In men, mesh has been shown to migrate into the spermatic cord, sometimes requiring surgical removal of a testicle (orchiectomy).

If you have experienced these serious complications from Covidien Parietex mesh and have required revision surgery, contact our attorneys for a free case evaluation.

Why Parietex Mesh Fails

Covidien introduced Parietex surgical mesh for ventral hernia repair in 1999. The company chose polyester fabric instead of polypropylene, used in most other hernia meshes. Parietex and Symbotex received FDA clearance through the 510(k) process as Class II devices, Symbotex in 2013, meaning Covidien avoided human clinical trials before marketing the products by claiming they were “substantially equivalent” to existing devices.

Unlike polypropylene, polyester is not chemically inert in the body. It can shrink significantly after implantation, its fibers can unravel and stiffen until the mesh turns rigid, and the material degrades faster than expected, which can cause the repair itself to fail. Plaintiffs allege polyester mesh causes greater degradation, higher rates of chronic infection, excessive shrinkage, and premature breakdown of protective collagen barriers. Covidien’s Parietex products feature anti-adhesion coatings, but these do not work as intended. The collagen barrier absorbs too quickly, exposing the polyester underneath and allowing it to adhere to internal organs. That is the theory the Patterson jury accepted when it found that Covidien failed to warn surgeons and awarded $88 million.

Products at Issue

Covidien hernia mesh products named in litigation include:

  • Parietex Composite (PCO) Mesh
  • Parietex Composite Mono PM Mesh
  • Parietex Composite PCO-OS (Open Skirt) Mesh
  • Parietex Composite PCO-OB Mesh
  • Parietex Composite Ventral Patch
  • Parietex Composite Parastomal Mesh
  • Parietex Optimized Composite Mesh
  • Parietex Optimized Open Skirt Mesh
  • Parietex ProGrip Self-Fixating Mesh
  • Parietex ProGrip Laparoscopic
  • Parietex Lightweight Monofilament Mesh
  • Parietex Monofilament Polyester Mesh
  • Parietex Plug and Patch System
  • Symbotex Composite Mesh (subject of the first bellwether trials)
  • Parietene DS Composite Mesh (polypropylene)
  • Parietene Polypropylene Mesh
  • Parietene ProGrip Mesh
  • Surgi Pro and SurgiPro Plug & Patch
  • Dextile Anatomical Mesh

Pursuing Compensation

If you required revision surgery due to complications from Covidien Parietex hernia mesh, you may be entitled to compensation. These are not routine surgical outcomes. Covidien failed to adequately warn doctors and patients about known risks, including shrinkage, degradation, migration, and erosion.

Compensation can cover medical expenses for revision surgeries and the pain and suffering caused by the device. A spouse may also have a separate claim for loss of consortium, as the plaintiff’s wife did in Patterson.

Who Qualifies

Our practice concentrates on Covidien Parietex cases where complications have necessitated one or more revision or removal surgeries. If your experience meets these criteria, we invite you to schedule a confidential consultation to discuss your legal options.

Why Choose Doyle APC

  • Over 28 Years of Product Liability Experience: Our practice focuses on holding manufacturers accountable for defective products, ranging from consumer goods and pharmaceuticals to medical implants, such as hernia mesh.
  • Boutique Representation, Deep Involvement: We are not a volume-based practice. We personally evaluate and litigate every case we accept. When we take on a matter, it’s because we believe in the client and are fully committed to achieving the best possible result.
  • Proven Track Record in Complex Cases: Our attorneys have led major class actions and complex litigation across the country, including high-stakes cases against prominent companies such as Apple, Honda, and Amazon, as well as leading device manufacturers. We’ve secured hundreds of millions of dollars for clients injured by defective products.
  • Contingency Representation: You pay nothing unless we recover compensation for you.

Frequently Asked Questions

Why only Covidien cases and not Bard?

Bard reached a major settlement in October 2024, resolving tens of thousands of claims through a settlement valued at more than $1 billion. That litigation is now in claims administration. Covidien cases remain in active litigation, with no settlement announced and an $88 million plaintiff verdict just returned in the first bellwether trial. We focus our resources where they still make a difference.

What if I don’t know which mesh I have?

This is a very common situation. Most patients are not told the specific brand or model of the mesh used in their surgery. The operative report from your surgery will usually name the manufacturer and model, and many hospitals now make those records available through a patient portal. We can also obtain the records for you to identify the exact product. Our firm only accepts cases involving Covidien Parietex mesh products.

What is the filing deadline in California?

In California, the statute of limitations for a product liability claim is generally two years from when the injury was discovered or reasonably should have been discovered. This discovery rule is critical in hernia mesh cases, as complications can arise many years after the initial surgery. Because these deadlines can be complex, it is essential to speak with an attorney as soon as you suspect your health problems may be linked to your mesh implant.

What is a bellwether trial, and does it decide my case?

A bellwether trial is a test case chosen from a large group of similar lawsuits, such as those in an MDL. The result binds only the parties to that case, but it shows both sides how a jury responds to the core evidence, and it heavily influences settlement negotiations for the thousands of remaining claims. The first Covidien bellwether trial, Patterson v. Covidien, began on July 13, 2026 and ended on August 4, 2026 with an $88 million verdict for the plaintiff. That result does not decide your case and does not entitle you to a similar amount. It does tell both sides how a jury weighs the central evidence that runs through nearly every Covidien file.

Does the $88 million verdict mean my case is worth $88 million?

No. That figure reflects one man’s injuries, one family’s losses, and the evidence presented in one trial under Alabama law. Awards in individual mesh cases vary enormously with the severity of injury, the number of revision surgeries, the medical documentation, and the state whose law applies. Most claims in litigation of this size resolve through negotiated settlement rather than trial, at values well below a headline verdict. What the verdict changes is the negotiating environment, not the value of any particular claim.

Another firm turned my case down. Why would you be different?

Many large, national law firms that handle mass torts operate on a volume-based model. They may decline or drop cases that require more intensive investigation or have complex medical facts. As a boutique product liability firm, we specialize in exactly these types of cases. We deliberately take on a smaller number of clients so that we can provide the in-depth analysis and personal attention that medically complex cases require and deserve.

What does it cost to hire your firm?

We represent all clients on a contingency fee basis. This means you pay no upfront costs or out-of-pocket fees. Our firm advances all costs of litigation. We only receive a fee if we successfully recover compensation for you. If there is no recovery, you owe us nothing.

Free Legal Consultation

If you have experienced complications from Covidien Parietex hernia mesh and required revision surgery, contact our office for a free case evaluation. Our attorneys will review your medical history, work to identify the specific mesh product involved, and determine whether your injuries may be related to a defective device.

Filing deadlines vary by state and can pass sooner than you expect, and they are not suspended by the verdict or by Covidien’s appeal. To schedule your free, confidential consultation with one of our attorneys, contact us today. There is no cost and no obligation.

GET A FREE LEGAL CONSULTATION

Footer

San Diego Office

Doyle APC Law Firm
550 West B St, 4th Floor
San Diego, CA 92101
Phone: (619) 736-0000
Fax: (619) 736-1111
(800) 736-9085

Copyright © 2026 DOYLE APC · Attorney Advertising
California Product Liability Attorneys

  • Privacy Policy
  • Terms of Use
  • Contact